Dr James Howard Wilson, MD in Buda, IL - Orthopaedic Surgery

Dr James Howard Wilson, MD is a Orthopaedic Surgery physician based in Buda, Illinois. Dr James Howard Wilson is licensed to practice in Illinois (license number 03643800) and his current practice location is 9291 Il Highway 40, Buda, Illinois. He can be reached at his office (for appointments etc.) via phone at (309) 895-1052.

NPI number for Dr James Howard Wilson is 1750579702 and his current mailing address is 9291 Il Highway 40, Buda, Illinois. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1750579702.

Contact Information

	Dr James Howard Wilson, MD
	9291 Il Highway 40, Buda, IL 61314-9451
	(309) 895-1052
	(309) 895-1052

Physician's Profile

Full Name	Dr James Howard Wilson
Gender	Male
Speciality	Orthopaedic Surgery
Location	9291 Il Highway 40, Buda, Illinois
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1750579702
Provider Enumeration Date: 10/03/2007
Last Update Date: 10/03/2007

Medical Identifiers

Medical identifiers for Dr James Howard Wilson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1750579702	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207X00000X	Orthopaedic Surgery	03643800 (Illinois)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr James Howard Wilson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr James Howard Wilson, MD 9291 Il Highway 40, Buda, IL 61314-9451 Ph: (309) 895-1052	Dr James Howard Wilson, MD 9291 Il Highway 40, Buda, IL 61314-9451 Ph: (309) 895-1052

News Archive

Delayed lactate measurements in sepsis patients increase risk of in-hospital death

The rising incidence of sepsis, a leading cause of in-hospital death, has prompted the Centers for Medicare and Medicaid Services to issue protocols known as care bundles to standardize and improve sepsis care.

Virtual Imaging to showcase Canon's advanced DR systems at RSNA 2009

Designed to improve today's routine radiographic procedures, the RadPRO® product line from Virtual Imaging, Inc., a Canon U.S.A., Inc. subsidiary, will feature Canon's current line of advanced portable and general digital radiography (DR) systems at the 2009 Radiological Society of North America Annual Meeting (RSNA 2009), taking place at McCormick Place, November 29 – December 3.

FDA supports new Hepatitis C drug from Vertex Pharmaceuticals

Vertex pharmaceuticals jumped 10 percent in value on the Nasdaq after U.S. regulators FDA said the company's experimental hepatitis C drug cures more patients than current therapies.

Indivior reports top-line results from RBP-7000 phase 3 trial for treatment of schizophrenia

Indivior PLC today announced top-line results from its phase 3 clinical trial of RBP-7000, an investigational drug in development for the treatment of schizophrenia. In this pivotal study, both doses of RBP-7000 tested, 90 mg and 120 mg administered once-monthly, met the primary endpoint with statistically and clinically significant reductions in the symptoms of acute schizophrenia over an 8-week treatment period.

Dr James Howard Wilson, MD - Orthopaedic Surgery in Buda, IL